Excess iron undermined bone load-bearing capacity through tumor necrosis factor-alpha-dependent osteoclastic activation in mice

被引:12
作者
Li, Junping [1 ,2 ]
Hou, Yanli [1 ,2 ]
Zhang, Shuping [2 ]
Ji, Hong [1 ]
Rong, Haiqin [1 ]
Qu, Guangbo [2 ]
Liu, Sijin [2 ]
机构
[1] Shandong Inst Endocrine & Metab Dis, Jinan 250062, Shandong, Peoples R China
[2] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, 18 Shuangqing Rd, Beijing 100085, Peoples R China
基金
中国国家自然科学基金;
关键词
iron overload; bone mass; bone resorption; bone strength;
D O I
10.3892/br.2012.6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Iron overload has been associated with bone mass loss. To elucidate the effects of excess iron on bone metabolism, an iron-overloading mouse model was established by administering iron-dextran at 250 mg/kg to female BALB/c mice. After 4 weeks, the mice were sacrificed and the biomechanical properties of the femurs were examined. The results suggested a notable decrease of the maximal bending stress and the modulus of bending elasticity in the femurs obtained from the excess iron-treated mice compared to the control mice. The levels of the serum osteocalcin, C-telopeptide of type I collagen (CTX-1) and tumor necrosis factor-alpha(TNF-alpha) were measured in order to investigate the underlying mechanism responsible for the excess iron-induced bone strength reduction. Overall, the results suggested that iron overload resulted in a marked reduction of bone load-bearing capacity through a TNF-triggered osteoclast differentiation and resorption mechanism.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 24 条
[1]   Hepatic and adipocyte cells respond differentially to iron overload, hypoxic and inflammatory challenge [J].
Andrews, M. ;
Arredondo, M. .
BIOMETALS, 2012, 25 (04) :749-759
[2]   Osteoclastic differentiation and function regulated by old and new pathways [J].
Blair, Harry C. ;
Zaidi, Mone .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2006, 7 (1-2) :23-32
[3]   Markers of bone remodeling in metastatic bone disease [J].
Fohr, B ;
Dunstan, CR ;
Seibel, MJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5059-5075
[4]   TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL [J].
Fuller, K ;
Murphy, C ;
Kirstein, B ;
Fox, SW ;
Chambers, TJ .
ENDOCRINOLOGY, 2002, 143 (03) :1108-1118
[5]  
Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]
[6]   Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation [J].
Ishii, Kiyo-aki ;
Fumoto, Toshio ;
Iwai, Kazuhiro ;
Takeshita, Sunao ;
Ito, Masako ;
Shimohata, Nobuyuki ;
Aburatani, Hiroyuki ;
Taketani, Shigeru ;
Lelliott, Christopher J. ;
Vidal-Puig, Antonio ;
Ikeda, Kyoji .
NATURE MEDICINE, 2009, 15 (03) :259-266
[7]   Tumor necrosis factor-α mediates osteopenia caused by depletion of antioxidants [J].
Jagger, CJ ;
Lean, JM ;
Davies, JT ;
Chambers, TJ .
ENDOCRINOLOGY, 2005, 146 (01) :113-118
[8]   TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand [J].
Lam, J ;
Takeshita, S ;
Barker, JE ;
Kanagawa, O ;
Ross, FP ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (12) :1481-1488
[9]   A crucial role for thiol antioxidants in estrogen-deficiency bone loss [J].
Lean, JM ;
Davies, JT ;
Fuller, K ;
Jagger, CJ ;
Kirstein, B ;
Partington, GA ;
Urry, ZL ;
Chambers, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) :915-923
[10]   Age-associated iron accumulation in bone: Implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation [J].
Liu, Gang ;
Men, Ping ;
Kenner, Gerry H. ;
Miller, Scott C. .
BIOMETALS, 2006, 19 (03) :245-251